New device maps brain tumors during surgery in first human test
NCT ID NCT07465796
First seen Mar 27, 2026 · Last updated May 18, 2026 · Updated 8 times
Summary
This early study tests a new device called the CIPHER System in 10 adults having surgery for a newly diagnosed brain tumor (glioma). The device is used during the operation to record brain signals from the tumor and surrounding areas. The main goal is to check if the device is safe and works as intended. Participants receive standard surgery and are followed for six weeks after.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Royal Melbourne Hospital, Department of Neurosurgery 4 East
RECRUITINGMelbourne, Victoria, 3050, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.